• Browse Industries
• Food Service

• NCC Health and Wellness SmartBrief
• Top Summaries
• NCC Reader Polls
• Archive
• RSS

• Find/Post Jobs

• Partner With Us

• About SmartBrief

• Reader Polls

FDA examines liver-damage reports tied to GSK's Alli, Xenical

The FDA is looking into more than 30 reports of liver damage in patients who took weight-loss drugs Alli and Xenical. The cases were reported between 1999 and October 2008. A spokeswoman for GlaxoSmithKline, which makes the treatments, said there is no proof that the products cause liver injury.

Google | 08/24

This story published in NCC Health and Wellness SmartBrief on 08/27/2009

Get stories like these delivered daily for FREE:

NCC Health and Wellness SmartBrief Designed specifically for food and beverage industry professionals, NCC Health and Wellness SmartBrief is a FREE, twice-weekly e-mail newsletter. It provides the latest news on health and wellness in the food and beverage industries. Learn more